Treatment of Stage 2 Macular Hole by Intravitreous Injection of Expansile Gas and Induction of Posterior Vitreous Detachment

Ophthalmology

Volumn 114, Issue 1, 2007, Pages 127-133

  Mori, Keisuke ^a   Saito, Sumiyo ^a   Gehlbach, Peter L ^b   Yoneya, Shin ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SULFUR HEXAFLUORIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE SURGERY; FEMALE; FOLLOW UP; HUMAN; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PATIENT POSITIONING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA HOLE; SLIT LAMP; VISUAL ACUITY; VITREOUS BODY DETACHMENT;

AGED; FEMALE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PRONE POSITION; PROSPECTIVE STUDIES; RETINAL PERFORATIONS; SULFUR HEXAFLUORIDE; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY; VITREOUS DETACHMENT;

EID: 33845792091     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.07.001     Document Type: Article

References (21)

1. Kelly N.E., and Wendel R.T. Vitreous surgery for idiopathic macular holes: results of pilot study. Arch Ophthalmol 109 (1991) 654-659
2. Wendel R.T., Patel A.C., Kelly N.E., et al. Vitreous surgery for macular holes. Ophthalmology 100 (1993) 1671-1676
3. Glaser B.M., Michels R.G., Kupperman B.D., et al. Transforming growth factor-beta 2 for the treatment of full-thickness macular holes: a prospective randomized study. Ophthalmology 99 (1992) 1162-1172
4. Freeman W.R. Vitrectomy surgery for full-thickness macular holes. Am J Ophthalmol 116 (1993) 233-235
5. Freeman W.R., Azen S.P., Kim J.W., et al. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes: results of a multicentered randomized clinical trial. Arch Ophthalmol 115 (1997) 11-21
6. de Bustros S., and Vitrectomy for Prevention of Macular Hole Study Group. Vitrectomy for prevention of macular holes: results of a randomized multicenter clinical trial. Ophthalmology 101 (1994) 1055-1059
7. Kim J.W., Freeman W.R., Azen S.P., et al. Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Am J Ophthalmol 121 (1996) 605-614
8. Smiddy W.E., Glaser B.M., Thompson J.T., et al. Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes: preliminary anatomic results of a multicenter prospective randomized study. Retina 13 (1993) 296-301
9. Thompson J.T., Smiddy W.E., Williams G.A., et al. Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery. Ophthalmology 105 (1998) 700-706
10. Paques M., Chastang C., Mathis A., et al. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Ophthalmology 106 (1999) 932-938
11. Ezra E., Gregor Z.J., and Moorfields Macular Hole Study Group. Surgery for idiopathic full-thickness macular hole: two-year results of a randomized clinical trial comparing natural history, vitrectomy, and vitrectomy plus autologous serum. Moorfields Macular Hole Study Group report no. 1. Arch Ophthalmol 122 (2004) 224-236
12. Benson W.E., Cruickshanks K.C., Fong D.S., et al. Surgical management of macular holes: a report by the American Academy of Ophthalmology. Ophthalmology 108 (2001) 1328-1335
13. Gass J.D. Idiopathic senile macular hole: its early stages and pathogenesis. Arch Ophthalmol 106 (1988) 629-639
14. Gass J.D. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 119 (1995) 752-759
15. Thompson J.T., Glaser B.M., Sjaarda R.N., and Murphy R.P. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol 119 (1995) 48-54
16. Banker A.S., Freeman W.R., Kim J.W., et al. Vision-threatening complications of surgery for full-thickness macular holes. Ophthalmology 104 (1997) 1442-1452
17. Park S.S., Marcus D.M., Duker J.S., et al. Posterior segment complications after vitrectomy for macular hole. Ophthalmology 102 (1995) 775-781
18. Chan C.K., Wessels I.F., and Friedrichsen E.J. Treatment of idiopathic macular holes by induced posterior vitreous detachment. Ophthalmology 102 (1995) 757-767
19. Krohn J. Duration of face-down positioning after macular hole surgery: a comparison between 1 week and 3 days. Acta Ophthalmol Scand 83 (2005) 289-292
20. Spaide R.F. Macular hole repair with minimal vitrectomy. Retina 22 (2002) 183-186
21. Hilton G.F., Tornambe P.E., and Retinal Detachment Study Group. Pneumatic retinopexy: an analysis of intraoperative and postoperative complications. Retina 11 (1991) 285-294